Matrix metalloproteinase 12 is an independent prognostic factor predicting postoperative relapse of conventional renal cell carcinoma - a short report

PURPOSE: Approximately 15% of clinically localised conventional renal cell carcinomas (cRCC) develop metastases within 5 years of follow-up. Sarcomatous cRCC is a highly malignant cancer of the kidney. The aim of our study was to identify biomarkers for estimating the postoperative progression of cR...

Descripción completa

Detalles Bibliográficos
Autores principales: Beres, Bence, Yusenko, Maria, Peterfi, Lehel, Kovacs, Gyula, Banyai, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881244/
https://www.ncbi.nlm.nih.gov/pubmed/34894337
http://dx.doi.org/10.1007/s13402-021-00650-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881244/
https://www.ncbi.nlm.nih.gov/pubmed/34894337
http://dx.doi.org/10.1007/s13402-021-00650-9

Ejemplares similares